C-mo is the solution providing a complete assessment of cough, adressing key use-cases across the patient management lifecycle.
C-mo Medical Solutions has raised $760K in total funding. The most recent round was Seed. The last funding was announced in January 2023.
C-mo Medical Solutions's investors include HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund, Novalis Biotechnology Incubation, European Institute of Innovation and Technology, Portugal Ventures.
C-mo Medical Solutions is headquartered in Caparica, Portugal.
C-mo is the solution providing a complete assessment of cough, adressing key use-cases across the patient management lifecycle.
C-mo Medical Solutions is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"C-mo Medical Solutions — Funding & Investors." VCBacked, January 31, 2023, https://www.vcbacked.co/company/c-mo-medical-solutions. Accessed August 14, 2026.
VCBacked. (2023). C-mo Medical Solutions — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/c-mo-medical-solutions
{{cite web |title=C-mo Medical Solutions — Funding & Investors |url=https://www.vcbacked.co/company/c-mo-medical-solutions |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated